AKT1 and Cerebral ischemia: As far as apoptosis is concerned, ginsenoside Rd may reduce cerebral ischemia-induced tau phosphorylation by decreasing the activity of glycogen synthase kinase-3β (GSK-3β) and enhancing the activity of protein kinase B (PKB/AKT) (Zhang et al., 2014).